bioAffinity Technologies (BIAF) Earnings Date & Reports
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
BIAF is expected to report earnings to fall 47.06% to -9 cents per share on November 12
Q3'25
Est.
$-0.09
Q2'25
Missed
by $0.07
Q1'25
Beat
by $0.01
Q4'24
Missed
by $0.05
Q3'24
Missed
by $0.01
The last earnings report on August 14 showed earnings per share of -17 cents, missing the estimate of -10 cents. With 32.12K shares outstanding, the current market capitalization sits at 6.63M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. BIAF showed earnings on August 14, 2025. You can read more about the earnings report here.